Refrigerator-Stable FluMist Submitted For Young Children
This article was originally published in The Pink Sheet Daily
Executive Summary
MedImmune submitted a supplemental BLA seeking use of refrigerator-stable intranasal flu vaccine FluMist to inoculate children ages 12 months to 59 months, the company announced July 31
You may also be interested in...
MedImmune’s FluMist Approved For Children As Young As Age Two
Firm will begin shipments immediately to make doses available for the 2007-2008 influenza season.
MedImmune’s FluMist Approved For Children As Young As Age Two
Firm will begin shipments immediately to make doses available for the 2007-2008 influenza season.
MedImmune Expects Initial Data From Head-To-Head Numax/Synagis Trial Before Nov. 23
While the firm anticipates a superiority finding, the study comparing its RSV therapies is powered for both superiority and non-inferiority, MedImmune execs say during Q3 call.